Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Genome-wide study of methotrexate clearance replicates SLCO1B1
2012
Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time
2011
Knowledge and intelligent computing system in medicine
2009 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
DNA cross‐link induced by trans‐4‐hydroxynonenal
2010
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)
2003
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Acute Lymphoblastic Leukemia
1998
Logistic regression and artificial neural network classification models: a methodology review
2002 Standout
Chlorambucil in Indolent Chronic Lymphocytic Leukemia
1998
Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States
2014
Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor
2002
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”
2010 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Pegaspargase: a review of clinical studies
2003
Peptide selection by class I molecules of the major histocompatibility complex
1993
Risk factors for brain relapse in patients with metastatic breast cancer
2004
Polymer conjugates as anticancer nanomedicines
2006 Standout
A review of evidence of health benefit from artificial neural networks in medical intervention
2002
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
1991 StandoutNature
Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia
2001
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Symptoms and prognosis in advanced cancer
2002
Immune Thrombocytopenic Purpura
2002 Standout
Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
2000
Does anthracycline administration by infusion in children affect late cardiotoxicity?
2004
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
2002
Natural compounds for cancer treatment and prevention
2009 Standout
PEGylation, successful approach to drug delivery
2005 Standout
Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial
2005
The AID Dilemma
2012 StandoutNobel
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Childhood acute lymphoblastic leukemia
2002
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Chronic Lymphocytic Leukemia
1995
Bone Marrow Transplantation in the Treatment of Children with Cancer: Current Status
1987
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
2009
Bone marrow and peripheral blood stem cell transplantation for malignancy.
1998
Childhood and adolescent cancer statistics, 2014
2014 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
The Biology of NKT Cells
2006 Standout
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival
2005
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
1999
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
Indirect comparisons of competing interventions
2005
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells
2007
Characterization of Naturally Occurring Minor Histocompatibility Peptides Including H-4 and H-Y
1990 Science
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
2007
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice.
1991
Bone Marrow Transplant
1990 Standout
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Costs and Benefits of Health Information Technology
2006 Standout
Revaccination of Children after Completion of Standard Chemotherapy for Acute Leukemia
2007
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
1987
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of S Richards being referenced
Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard arm
2003
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials
2000
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival
1989
CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3
1991
Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials*
1995
Molecular Definition of a Mitochondrially Encoded Mouse Minor Histocompatibility Antigen
1989
Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin
1997
Triplex targeted genomic crosslinks enter separable deletion and base substitution pathways
2005
Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain
2012
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI
1998
CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials
2003
BONE-MARROW TRANSPLANTATION HAS A LIMITED ROLE IN PROLONGING SECOND MARROW REMISSION IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA
1986
Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X
1997
A Comparison of Cox Regression and Neural Networks for Risk Stratification in Cases of Acute Lymphoblastic Leukaemia in Children
1999